Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer

(2009) G. Viale et al.   ANNALS OF ONCOLOGY

Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer

(2009) Bent Ejlertsen et al.   JNCI-Journal of the National Cancer Institute

Re: Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer

(2009) M. Debled et al.   JNCI-Journal of the National Cancer Institute

Vascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanisms

(2008) R A A Mohammed et al.   HISTOPATHOLOGY

Expression of BRCA1 protein in breast cancer and its prognostic significance

(2008) Emad A. Rakha et al.   HUMAN PATHOLOGY

D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma

(2008) Joseph T. Rabban et al.   HUMAN PATHOLOGY